Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

56.48
Delayed Data
As of May 27
 +0.09 / +0.16%
Today’s Change
45.69
Today|||52-Week Range
61.70
+6.93%
Year-to-Date
3 Dividend Growth Stocks to Buy in June
7:58am / MotleyFool.com - Paid Partner Content
Calpers seeks more access to Exxon's board
May 24 / FT.com - Paid Partner Content
Merck Gets Favorable Opinion From CHMP For Its ZEPATIER
May 27 / Benzinga - Paid Partner Content
Pfizer Wants to Be Seen as an Oncology Powerhouse
May 24 / TheStreet.com - Paid Partner Content
Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases
May 26 / MotleyFool.com - Paid Partner Content
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
May 19 / MotleyFool.com - Paid Partner Content
Market Indexes Higher With Volatility Lower
May 25 / GuruFocus News - Paid Partner Content
Multibillion-dollar pharma levy proposed in superbugs battle
May 18 / FT.com - Paid Partner Content
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
May 25 / MotleyFool.com - Paid Partner Content
Pfizer to trial triple-combination cancer treatment
May 09 / FT.com - Paid Partner Content

Today’s Trading

Previous close56.39
Today’s open56.50
Day’s range56.23 - 56.84
Volume7,508,752
Average volume (3 months)9,814,105
Market cap$153.9B
Dividend yield3.26%
Data as of 4:03pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.51%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-7.92%
P/E ratio34.6
Price/Sales3.87
Price/Book3.46

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+9.50+1.14%
NVSNovartis-0.03-0.04%
BMYBristol-Myers Squibb+0.58+0.82%
NVONovo Nordisk-0.61-1.09%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs